Seroprevalence of SARS-CoV-2 antibodies in a national hospital and affiliated facility after the second epidemic wave of Japan

Affiliations

• ¹ Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
• ² Department of Laboratory Testing Center, Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan.
• ³ Center for Medical Informatics Intelligence, National Center for Global Health and Medicine, Tokyo, Japan.
• ⁴ Department of Refractory Viral Infection, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.
• ⁵ Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: mizoue@hosp.ncgm.go.jp.
• ⁶ Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
• ⁷ Research Institute, National Center For Global Health and Medicine, Tokyo, Japan.
• ⁸ Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan.
• ⁹ Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.